卫生研究

参考文献

1 OECD.OECD guideline for the testing of chemicals,skinsensitization[S].Paris:OECD,1992.http://iccvam.niehs.nih.gov/methods/immunotox/llnadocs/OECDtg406.pdf.

2贺锡雯.毒理学安全性评价中动物替代方法的研究和应用[J].中华预防医学杂志,2006,40(3):215-216.

3刘珍.化妆品安全性评价中皮肤毒性若干替代实验方法的研究[D].上海:第二军医大学卫生毒理学教研室,2009.

4房军,金银龙.化妆品原料危险性评估中替代试验研究进展[J].香料香精化妆品,2008,2(1):37-39.

5 ZUANG V,BARROSO J,BREMER S,et al.ECVAM technicalreport on the status of alternative methods for cosmetics testing(2008-2009)[R].European Union,2010.http://ecvam.jrc.it/publication/JRC58991_2010-05-30-ecvam%20technical%20report%202008-2009%20final%20_3_.doc%5B1%5D.pdf.

6 KIMBER I,WEISENBERGER C.A murine local lymph nodeassay for the identification of contact allergens.Assaydevelopment and result of an initial validation study[J].Archtoxicol,1989,63:274-283.

7中国替代方法研究中心.皮肤致敏动物试验的减少和优化[R].http://www.vitrotox.com/show_new.asp?id=647&bigclassname=专题研究.

8程树军,焦红.实验动物替代方法原理与应用[M].北京:科学出版社,2010:227-250.

9 OECD.OECD guideline for the testing of chemicals,skinsensitisation:local lymph node assay[S].Paris:OECD,2010.http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD-TG429-2010.pdf.

10 OECD.OECD guideline for the testing of chemicals,skinsensitisation:local lymph node assay[S].Paris:OECD,2002.http://iccvam.niehs.nih.gov/methods/immunotox/llnadocs/OECD429.pdf.

11 MCGARRY H F.The murine local lymph node assay:regulatoryand potency considerations under REACH[J].Toxicology,2007,238(2-3):71-89.

12国家标准化管理委员会,中华人民共和国国家质量监督检验检疫总局.GB/T21827-2008化学品皮肤变态反应试验局部淋巴结方法[S].北京:中国标准出版社,2008.

13 KREILING R,HOLLNAGEL H M,HARENG L,et al.Comparison of the skin sensitizing potential of unsaturatedcompounds as assessed by the murine local lymph node assay(LLNA)and the guinea pig maximization test(GPMT)[J].FoodChem Toxicol,2008,46:1896-1904.

14 TAKEYOSHI M,YAMASAKI K,YAKABE Y,et al.Developmentof non-radio isotopic endpoint of murine local lymph node assaybased on 5-bromo-2'-deoxyuridine(BrdU)incorporation[J].Toxicol Lett,2001,119:203-208.

15 OECD.OECD guideline for the testing of chemicals,skinsensitisation:local lymph node assay:BrdU-ELISA[S].Paris:OECD,2010.http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD-TG442B.pdf.

16 TAKEYOSHI M,SAWAKI M,YAMASAKI K,et al.Assessmentof statistic analysis in non-radioisotopic local lymph node assay(non-RI-LLNA)withα-hexylcinnamic aldehyde as an example[J].Toxicology,2003,191:259-263.

17黄海雄,庾蕾,何国群,等.应用BrdU—ELISA法检测化学物皮肤致敏性研究[J].职业与健康,2008,24(12):1133-1135.

18 YAMASHITA K,IDEHARA K,FUKADA N,et al.Developmentof a modified local lymph node assay using ATP measurement asan endpoint[J].AATEX,2005,11:136-144.

19 OMORI T,IDEHARA K,KOJIMA H,et al.Interlaboratoryvalidation of the modified murine local lymph node assay basedon adenosine triphosphate measurement[J].J Pharmacol ToxicolMethods,2008,58(1):11-26.

20 IDEHARA K,YAMAGISHI G,YAMASHITA K,et al.Characterization and evaluation of a modified local lymph nodeassay using ATP content as a non-radio isotopic endpoint[J].JPharmacol Toxicol Methods,2008,58:1-10.

21 OECD.OECD guideline for the testing of chemicals,skinsensitisation:local lymph node assay:DA[S].Paris:OECD,2010.http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD-TG442A.pdf.

22 JOWSEY I R,BASKETTER D A,WESTMORELAND C,et al.Afuture approach to measuring relative skin sensitising potency:aproposal[J].Toxicology,2006,26:341-350.

23 SILVIA C.Validation of alternative endpoints for the LLNA:General considerations[J].AATEX,2007,14:425-427.

24张宏伟,景欣月.小鼠局部淋巴结实验方法检测化学物致敏性[J].中国自然医学杂志,2005,7(2):111-113.

25刘珍,刘俊平,万旭英,等.化妆品安全性评价中小鼠局部淋巴结试验方法的改进[J].卫生研究,2009,38(5):585-289.

26 ANDERSON S E,SIEGEL P D,MEAD B J,et al.The LLNA:abrief review of recent advances and limitations[J].J Allergy,2011,2011:1-10.

27 AEBY P,ASHIKAGA T,BESSOU-TOUYA S,et al.Identifyingand characterizing chemical skin sensitizers without animaltesting:Colipa’s research and method development program[J].Toxicol in vitro,2010,24:1465-1473.

28 TARAMA R,KATO H,ISHIKAWA Y,et al.Gene expressionchanges induced by type IV allergy-inducible chemicals indendritic cells[J].J Veterinary Medical Science,2008,70:673-680.

29 JOHASSON H,LINDSTEDT M,ALBREKT A S,et al.A genomicbiomarker signature can predict skin sensitizers using a cell-basedin vitro alternative to animal tests[J].BMC Genomics,2011,12:399.

30 TAILHARDAT M C,DUQUENNOY M B,PELLEDE Q D,et al.Chemicals with weak skin sensitizing properties can be identifiedusing low-density micro arrays on immature dendritic cells[J].Toxicol.Lett,2007(174):98-109.

31 GERBERICK G F,VASSALLO J D,BAILEY R E,et al.Development of a peptide reactivity assay for screening contactallergens[J].Toxicol Sci,2006,81:332-343.

32 GERBERICK G F,TROOTMAN J A,FOERTACH L M,et al.Investigation of peptide reactivity of pro-hapten skin sensitizersusing a proxiodase-peroxide oxidation system[J].Toxical Sci,2009,112:164-174.

33 TROUTMAN J A,FOERTSCH L M,KERN P S,et al.Theincorporation of lysine into the peroxidase peptide reactivity assayfor skin sensitization Assessments[J].Toxicol Sci,2011,122:422-436.

34 REUTER H,SPIEKER J,GERLACH S,et al.In vitro detection ofcontact allergens:development of an optimized protocol usinghuman peripheral blood monocyte-derived dendritic cells[J].Toxicol in vitro,2011,25:315-323.

35 TAKAHASHI T,KIMURA Y,SAITO R,et al.An in vitro test toscreen skin sensitizers using a stable THP-1-derived IL-8 reportercell line,THP-G8[J].Toxicol Sci,2011,9:237-237.

36 FACY V,FLOURET V,REGNIER M,et al.Reactivity oflangerhans cells in human reconstructed epidermis to knownallergens and UV radiation[J].Toxical In Vitro,2005,19(6):787-795.

37 UCHINO T,TAKEZAWA T AND IKARASHI Y.Reconstructionof three-dimensional human skin model composed of dendriticcells,keratinocytes and fibroblasts utilizing a handy scaffold ofcollagen vitrigel membrane[J].Toxical In Vitro,2009,23:333-337.

38 ECVAM.State on the application of the skinethicTM human skinmodel for skin corrosivity testing[R],Ispra.2006.http://ecvam.jrc.ec.europa.eu/publication/ESAC25_statement_SKINETHIC_correction_on181206_C.pdf

39 SLODOWNIK D,GRINBERG I,SPIRA R M,et al.The humanskin/chick chorioallantoic membrane model accurately predictsthe potency of cosmetic allergens[J].Exper Dermatol,2009,18:409-413.

40陈树军.化妆品风险评估及替代技术的应用[R].广东检验检疫技术中心食品实验室,2010.http://www.vitrotox.com/uploadfile/UploadFile/2010102914023667.pdf.

41 DAVIES M,PENDLINGTON R U,PAGE L,et al.Determiningepidermal disposition kinetics for use in an integrated nonanimalapproach to skin sensitization risk assessment[J].Toxicol Sci,2011,119:308-318.

42 BASKETTER D A,DARLENSKI R,FLUHR J W,et al.Skinirritation and sensitization:mechanisms and new approaches forrisk assessment[J].Skin Pharmacol Physiol,2008,21:191-202.

43 APTULA A O,PATLEWICZ G,ROBERTS D W,et al.Non-enzymatic glutathione reactivity and in vitro toxicity:a non-animal approach to skin sensitization[J].Toxicol In Vitro,2006,20:239-247.